Source: iQoncept / Shutterstock
Turnstone Biologics (NASDAQ:TSBX) just reported results for the first quarter of 2024.
- Turnstone Biologics reported earnings per share of -85 cents. This was below the analyst estimate for EPS of -78 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/tsbx-stock-earnings-turnstone-biologics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC